HIM
IMI

Hillsdale Investment Management’s Intermolecular, Inc. IMI Stock Holding History

Hillsdale Investment Management’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-6,900
Closed -$50K – 589
2013
Q2 		$50K Buy
+6,900
New +$58.7K 0.02% 427

Other funds holding IMI

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Hillsdale Investment Management's IMI Position: Q3 2013 in Review

Hillsdale Investment Management sold out of Intermolecular, Inc. (IMI) in Q3 2013, closing a stake of 6,900 shares — an estimated $50K sold.

Hillsdale Investment Management first reported a position in IMI in Q2 2013 and held it in 1 quarter. The position peaked at $50K in Q2 2013. 62 funds tracked by Wall St. Rank hold IMI as of Q3 2013.

  • Hillsdale Investment Management reported no remaining Intermolecular, Inc. position as of Q3 2013 after selling out during the quarter.
  • Hillsdale Investment Management sold 6,900 Intermolecular, Inc. shares in Q3 2013, an estimated $50K.
  • Hillsdale Investment Management first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 1 quarter.
  • Hillsdale Investment Management's Intermolecular, Inc. position peaked at $50K in Q2 2013.
  • 62 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2013.

Based on Hillsdale Investment Management's 13F filing for Q3 2013, filed 14 Nov 2013.